Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J To End Johnson’s Baby Powder Sales In North American Markets, But Maintains Safety Convictions

May 21 2020

• By Eileen Francis

Related Content

J&J’s Talc Winning Streak Continues With Calif. Mesothelioma Verdict

Nov 24 2017

FDA-Proposed Talc Testing Methods Likely Would Find Particles Of Concern; Then What?

Mar 06 2020

J&J International Baby, Beauty Lines Could Lead Trimming 10% Of Consumer Portfolio

Jan 22 2020

J&J Producing Tylenol ‘24-7’ As US OTC Sales Jump 35% On Pandemic-Driven Stockpiling

Apr 14 2020

Asbestos In Johnson's Baby Powder May Come From Test Labs, J&J Says

Oct 29 2019

Related Companies

Johnson & Johnson

Additional Topics

Advertising, Marketing & Sales Legal Issues Cosmetics Commercial Safety Ingredients Consumer

More from Ingredients & Safety

More from HBW Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.